Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of ACVBP Followed by Autologous Stem Cell Transplantation in Case of BCL-2 Overexpression in Non Previously Treated Patients Aged 60 Years or Less With Low-Intermediate Risk Diffuse Large B-Cell Lymphoma

NCT00169130 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00169130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of ACVBP Followed by Autologous Stem Cell Transplantation in Case of BCL-2 Overexpression in Non Previously Treated Patients Aged 60 Years or Less With Low-Intermediate Risk Diffuse Large B-Cell Lymphoma
Lead sponsor
Lymphoma Study Association
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 1999
Completion date
Not reported
Enrollment
300
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, large-cell, diffuse